GLP1R and type 2 diabetes mellitus: GLP-1 receptor agonists (GLP-1RAs) are a novel class of hypoglycemic agents that improve cognitive function in individuals with type 2 diabetes through various mechanisms, including promoting neurogenesis, inhibiting neuroinflammation, reducing oxidative stress, and enhancing synaptic plasticity.